Attached files

file filename
EX-3.5 - ARTICLES OF INCORPORATION FILED IN THE STATE OF NEVADA - TherapeuticsMD, Inc.dex35.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - TherapeuticsMD, Inc.dex312.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - TherapeuticsMD, Inc.dex311.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - TherapeuticsMD, Inc.dex322.htm
EX-10.14 - RESIGNATION OF ANDREW GOLDEN - TherapeuticsMD, Inc.dex1014.htm
EX-10.09 - SEATAC'S PROPOSAL TO ACCEPT COLLATERAL - TherapeuticsMD, Inc.dex1009.htm
EX-10.11 - JOINT DIRECTION TO RELEASE PLEDGED INTERESTS FROM ESCROW - TherapeuticsMD, Inc.dex1011.htm
EX-10.15 - RESIGNATION OF CHARLES RICHARDSON - TherapeuticsMD, Inc.dex1015.htm
EX-10.13 - RESIGNATION OF LARRY NEWMAN - TherapeuticsMD, Inc.dex1013.htm
EX-10.10 - AGREEMENT, ACKNOWLEDGMENT AND CONSENT BETWEEN THE COMPANY AND SEATAC - TherapeuticsMD, Inc.dex1010.htm
EX-10.16 - RESIGNATION OF KIMBERLY SARUBBI - TherapeuticsMD, Inc.dex1016.htm
EX-10.12 - TRADEMARK ASSIGNMENT AND AGREEMENT - TherapeuticsMD, Inc.dex1012.htm
10-Q - FORM 10-Q - TherapeuticsMD, Inc.d10q.htm
EX-3.4 - ARTICLES OF CONVERSION FILED IN THE STATE OF NEVADA - TherapeuticsMD, Inc.dex34.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of AMHN, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2010 as filed with the Securities and Exchange Commission on August 3, 2010 (the “Report”), I, Robert Cambridge, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Robert Cambridge

Robert Cambridge

Chief Executive Officer

August 3, 2010

A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

19